Please note that following CME Group’s annual revision to their exchange fees, which will be effective on 1 February 2024, there will be a revision to your commission fees.
For more information, please refer to this exchange circular.
For enquiries, please approach your account manager.
Revision of Transaction Fees for CME Group (CME/CBOT/NYMEX/COMEX) Contracts with Effect from 1 April 2026
Get access to a wide variety of products and trade on our winning platforms.
250 North Bridge Road, Raffles City Tower, #07-01, Singapore 179101 | Copyright © 2024. All Rights Reserved.
Phillip Nova Pte Ltd | A member of PhillipCapital | Company Reg No: 198305695G
Phillip Nova Pte Ltd (Co. Reg. No. 198305695G) holds a Capital Markets Services License issued by the Monetary Authority of Singapore, for dealing in stocks, futures/derivatives contracts and leveraged foreign exchange, and is an exempt financial adviser.
All forms of investments carry risks, and is not suitable for all investors as it can result in losses exceeding deposits or principal amount, therefore please ensure that you fully understand the risks, fees and costs involved by reading our Risk and Disclosure Statements and Disclaimer.
For more information on how we handle your personal information, please refer to our Privacy Policy.
This advertisement has not been reviewed by the Monetary Authority of Singapore.
EN 
CN 
